ST

Sameer Thakur

Active Director Director DIN 10915255
DIN 10915255 First appointment Jan 2025 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Sameer Thakur

Data last updated:

Sameer Thakur is a Director at Wynmed Pharmaceutical Private Limited (since 2025) and Director at Wyntech Construction Private Limited (since 2025). The companies operate in Paper.

DIN 10915255
Primary Designation Director
Industry Paper
First Appointment 30 Jan 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Feb 20252025Active
Wyntech Construction Private Limited U43900HP2025PTC011405
Director30 Jan 20252025Active

Board colleagues of Sameer Thakur

Directorship timeline

Open interactive timeline →
Wynmed Pharmaceutical Private Limited
Wyntech Construction Private Limited
Premium access

Shareholding and investment profile for Sameer Thakur

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sameer Thakur

Sameer Thakur currently holds 2 directorships: Wynmed Pharmaceutical Private Limited (Director, since 12 Feb 2025); Wyntech Construction Private Limited (Director, since 30 Jan 2025).

Sameer Thakur was first appointed on 30 Jan 2025 as Director at Wyntech Construction Private Limited.

The current boards of Sameer Thakur's companies include Suresh Kumar (Wynmed Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available